Blog

At the beginning of February, Gilead Sciences announced that United States Food and Drug Administration (FDA) approval was obtained for Trodelvy® (sacituzumab govitecan-hziy). This is for HR+ HER2- metastatic patients who experience disease progression after hormone therapy and two or more systemic therapies (such as chemotherapies).

When diagnosed with secondary breast cancer, all of the medical terminologies can be very overwhelming. This three part series of posts will tell you a little bit more about the main classifications of secondary breast cancer that are used to direct medical treatments.

At the end of January, ORSERDU™ (elacestrant) received Food and Drug Administration (FDA) approval as a new oral treatment for ER+ HER2- metastatic breast cancer in the United States. Endocrine therapy (also known as hormone therapy), with either aromatase inhibitors (AI) or fulvestrant, plus a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor is the recommended first-line standard-of-care for metastatic ER+ HER2- breast cancer.

We are proud to launching our Clinical Trial Registry to expand on our Patient Trial Advocate service. Our esteemed chairperson, Proffessor David Cameron, comments on the project: “We realise that many patients with secondary breast cancer want, and deserve, the chance to consider taking part in a clinical trial.

SBC & Me Date of diagnosis? 27th September 2021, primary diagnosis following examination, mammogram, ultrasound and punch biopsy - IDC.

SBC & Me Date of diagnosis? January 2022 Current treatment line?

When diagnosed with secondary breast cancer, all of the medical terminologies can be very overwhelming. This three part series of posts will tell you a little bit more about the main classifications of secondary breast cancer that are used to direct medical treatments.

SBC & Me Date of diagnosis? March 2021 Current treatment line?

SBC & Me Date of diagnosis? Primary May 19 Secondary September 19 Current treatment line?

SBC & Me Date of diagnosis? Dec 2019 Stage 3 March 2020 Stage 4 Current treatment line?

SBC & Me How does secondary breast cancer affect your life? It’s nearly 2 years since I was diagnosed straight to stage 4.

SBC & Me How does secondary breast cancer affect your life? I now try to live each day feeling happy and positive.

SBC & Me Date of diagnosis? 21/4/21 Current treatment line?

SBC & Me How does secondary breast cancer affect your life? Slows me down, tiredness more often than not, really have to plan days out trips around treatment times.

Earlier this month secondary breast cancer patient and Make 2nds Count supporter, Anne Blacklock, signed up to take part in our Make Christmas Count Campaign as one of our Bauble Sellers. We wanted to share Anne's story with you, and why she chose to support the campaign this Christmas.